Title : A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease - Farlow_2000_Eur.Neurol_44_236 |
Author(s) : Farlow M , Anand R , Messina J, Jr. , Hartman R , Veach J |
Ref : Eur Neurol , 44 :236 , 2000 |
Abstract : |
PubMedSearch : Farlow_2000_Eur.Neurol_44_236 |
PubMedID: 11096224 |